MBD2 and acute myeloid leukemia: To explore the potential clinical relevance of MBD2 expression in AML patients and in the normal population, we searched the GEPIA website and found that MBD2 was overexpressed in several types of cancer, such as AML (Fig. 1A and Supplementary Fig. S1).